Synthetic compound may lead to drugs to fight pancreatic, lung cancer
March 10th, 2011 - 5:23 pm ICT by ANIWashington, Mar 10 (ANI): Scientists have uncovered a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.
Researchers at UT Southwestern Medical Center are testing the compound’s effectiveness at fighting tumors in mice. If it is successful, they will then work to develop a drug based on the compound to combat pancreatic and non-small cell lung cancer, two cancer types in which this particular enzyme, TBK-1, often is required for cancer cell survival.
“Our prediction is that TBK-1 is a good pharmacological intervention target for a subset of lung and pancreas cancers that are addicted to the activity of this enzyme. We believe there is a large population of cancer patients that could respond to inhibition of this activity,” said Dr. Michael White, professor of cell biology and senior author of the study in the Feb. 18 issue of Molecular Cell.
The investigation, which lasted three and a half years, revealed how activation of the natural virus-fighting protein TBK-1 is hijacked in cancer cells to support growth and survival.
More than 250,000 compounds were screened to find one that would inhibit the enzyme’s cancer-protection mechanism. The most effective, a compound called 6-aminopyrazolopyrimidine developed in collaboration with pharmaceutical company Amgen, blocked TBK-1’s effects in 40 percent to 50 percent of the non-small cell lung cancer and pancreatic cancer tissue cultures tested, reducing cancer growth.
“We found a biological activity that some cancer cells need to be able to survive, and we found a way to turn it off,” said Dr. White.
“We’ve illuminated the dark matter of regulation of an incredibly important oncogenic survival pathway,” he said. (ANI)
- Molecule that can starve cancer cells and tumors they produce identified - Sep 19, 2010
- This jab could revolutionise cancer treatment - Apr 15, 2011
- New drugs to kill cancers minus side-effects - May 21, 2012
- Soy 'ups radiation's ability to destroy lung cancer cells' - Apr 02, 2011
- 'Low oxygen levels drive cancer growth' - May 06, 2012
- Targeted drug therapy shows promise against deadly form of lung cancer - Nov 02, 2010
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- Green peppers, chamomile tea may protect against inflammation - Jul 09, 2010
- New drug shows dramatic results in reducing lung cancer tumours - Jun 23, 2010
- Modified bone drug kills malaria parasite - Feb 28, 2012
- Vaccine that stops all tumours in their tracks to be available by 2013-end - Apr 15, 2011
- Possible new treatment strategies for pancreatic cancer found - Mar 04, 2011
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Potential therapeutic target for pancreatic cancer identified - Feb 24, 2010
- 'Smart' lung cancer drug shows promise - Oct 28, 2010
Tags: cancer cell, cancer cells, cancer growth, cancer protection, cancer tissue, cancer types, cell lung cancer, cell survival, dr white, growth researchers, natural virus, non small cell lung cancer, pharmacological intervention, small cell lung cancer, southwestern medical center, synthetic compound, tissue cultures, ut southwestern medical, ut southwestern medical center, viral enzyme